
Modeling The Cost-Effectiveness of The All Oral, Direct-Acting Antiviral Regimen Daclatasvir Plus Sofosbuvir In Patients Co-Infected With Hepatitis C Virus (Hcv) And Hiv
McEwan, P, Ward, T, Webster, S, Kalsekar, A, Brenner, M, Yuan, YVolume:
18
Langue:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.2213
Date:
November, 2015
Fichier:
PDF, 53 KB
english, 2015